Navigation Links
AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
Date:10/3/2008

control of AMT. Actual results could differ materially from current expectations due to a number of factors and uncertainties affecting AMT's business, including, but not limited to, the timely commencement and success of AMT's clinical trials and research endeavors, delays in receiving U.S. Food and Drug Administration or other regulatory approvals (i.e. EMEA, Health Canada), market acceptance of AMT's products, effectiveness of AMT's marketing and sales efforts, development of competing therapies and/or technologies, the terms of any future strategic alliances, the need for additional capital, the inability to obtain, or meet, conditions imposed for required governmental and regulatory approvals and consents. AMT expressly disclaims any intent or obligation to update these forward-looking statements except as required by law. For a more detailed description of the risk factors and uncertainties affecting AMT, refer to the prospectus of AMT's initial public offering on June 20, 2007, and AMT's public announcements made from time to time.

http://www.amtbiopharma.com


'/>"/>
SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Incorporated Announces Third Quarter 2007 Financial Results
3. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
4. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
7. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
8. PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy
9. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
10. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
11. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015   Regulus Therapeutics ... company leading the discovery and development of innovative ... G. Xanthopoulos , Ph.D. has resigned as President ... of Regulus, Board of Directors, effective today, to ... Grint, M.D., who previously served as Chief Medical ...
(Date:6/1/2015)... , June 1, 2015 The nuclear ... by 2020 at a CAGR of 12.08%. Nuclear medicine ... diseases. The two major types of Nuclear imaging used ... was the mainstream modality for nuclear medicine applications like ... to change because of global shortage of molybdenum-99 isotope ...
(Date:6/1/2015)... DURHAM, N.C. , June 1, 2015  bioMérieux, ... vitro diagnostics, has been invited to join the ... of antibiotic use in the U.S. as a means ... various sectors, will gather tomorrow, June 2, 2015, to ... next five years to slow the emergence of antibiotic-resistant ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 2North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 3bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3
... Sept. 13, 2011 Rare Disease Therapeutics, Inc. (RDT) ... Immune F(ab,)2 (Equine) Injection) is now available on the ... owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS). ... approved by the United States Food and Drug Administration ...
... CARLSBAD, Calif., Sept. 13, 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ... announced that management will present a company overview at UBS, ... 2011 at 1:30 p.m. ET at the Grand Hyatt New ... will be available on the "Investors & Media" section of ...
Cached Medicine Technology:Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation 2Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation 3Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation 4
(Date:6/1/2015)... 2015 The Muscular Dystrophy Association ... in participating in the sold out 2015 Bank ... secure guaranteed entry by signing up through the ... space is limited. , This national endurance program ... and abilities, and a supportive community of teammates, ...
(Date:6/1/2015)... June 01, 2015 Sharenote, a leading ... for the Healthcare Industry this week in Louisiana. The ... in four days to provide potential providers with the ... profitability, and monitor risk within their network. , ... and is being used by more than 250 practices. ...
(Date:6/1/2015)... More than 22 million children may miss out on milk’s ... they lose access to free or reduced-price meal programs. June ... companies are on a mission to bring more nutritious milk ... , In many cases, food insecure children depend on ... bulk of their daily nutrition. Although the National School Lunch ...
(Date:6/1/2015)... Listen to Volvo’s Director of Connectivity Strategy, Martin Kristensson, ... data to create better customer oriented services. Flanking him ... Celaya Gonzalez, CIO at MAPFRE, and Silvan Rath, CEO ... MAPFRE are well versed in capturing complex data and ... Award winning start-up ParkTAG offer an exciting new perspective, ...
(Date:6/1/2015)... session, entitled “Building the Blueprint for Tomorrow’s Vehicle Software,” ... Automotive Americas, senior representatives from Ford and Delphi, and ... Andy Gryc of CX3 Marketing. The discussion will focus ... in connected vehicles and autonomous cars, and will address ... can fit into new vehicle software. , The ...
Breaking Medicine News(10 mins):Health News:Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum 2Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 3
... Bioponic,Phytoceuticals, Inc. (OTC Bulletin Board: BPYT) ... Barbara Anne Nabrit-Stephens, MD, MBA,FAAP has joined ... a board-certified pediatrician with over 30 years ... Dr. Nabrit-Stephens will,help validate and formulate Bioponic,s ...
... mechanism, that leads to adverse reactions identified, officials add ... products have now been found in at least 10 ... surveillance measures to ensure the safety of the blood ... officials said contaminated lots of the blood thinner have ...
... and Higher Maintenance and Fuel Costs to ... ... Corporation,(Nasdaq: AIRM ), the largest air medical transportation company ... Based on preliminary 2008 first quarter results, total community-based,patient ...
... Triple-S,Management Corporation (NYSE: GTS ) today announced ... first quarter ended March 31, 2008,before the market opens ... Executive Officer, and Juan-Jose Roman, Finance Vice President and,Chief ... these,results and the outlook for the company at 10:00 ...
... N.J., April 22 Medco Health,Solutions, Inc., (NYSE: ... agreement with,UnitedHealth Group to provide pharmacy benefit services ... the next generation of collaboration with,UnitedHealth Group, delivering ... Medco chairman and CEO. "This agreement advances,our relationship ...
... MILLION MEANS GREATER EXPANSION OF COMMUNITY-BASED BEHAVIORAL ... HEALTH CARE SERVICES ACROSS ... ValueOptions(R) New,Mexico, the behavioral health organization that serves the ... additional $3,million to behavioral health care providers to further ...
Cached Medicine News:Health News:Bioponic Phytoceuticals Appoints Renowned Physician Dr. Barbara Nabrit-Stephens to Scientific Advisory Board 2Health News:Bioponic Phytoceuticals Appoints Renowned Physician Dr. Barbara Nabrit-Stephens to Scientific Advisory Board 3Health News:FDA: Contaminated Heparin Found in 11 Countries 2Health News:FDA: Contaminated Heparin Found in 11 Countries 3Health News:FDA: Contaminated Heparin Found in 11 Countries 4Health News:Air Methods Provides 1st Quarter Update 2Health News:Air Methods Provides 1st Quarter Update 3Health News:Triple-S Management Corporation Schedules First-Quarter Earnings Release and Webcast 2Health News:Medco, UnitedHealth Group Announce Pharmacy Services Agreement 2Health News:ValueOptions(R) New Mexico Provides $10.3 Million for Community Behavioral Health Care Organizations 2
Coibri handle. Pierse tips with 6 mm platform. 2.5 mm angled tips. Manufactured in titanium....
Straight shafts with 2.0 mm, 1 x 2 Elschnig style teeth. Serrated handle with polished finish. Handle: Wide....
Straight shafts with 45 degrees, 0.12 mm, 2 x 3 teeth and tying platform. Serrated handle with polished finish....
Straight shafts with 0.1 mm Pierse tips. Flat smooth handle with dull finish....
Medicine Products: